Journal Logo

Articles by J. F. Falantes

ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA-FLUGAZA PHASE III CLINICAL TRIAL: PF216

Paiva, B.; Martínez-Cuadrón, D.; Bergua, J. M.; More

HemaSphere. 3:59, June 2019.